Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Preventing hepatitis C: what do positive injectors do?

Susan J Carruthers1

  • 1National Drug Research Institute, Curtin University, Perth, Western Australia. s.carruthers@curtin.edu.au

Drug and Alcohol Review
|August 4, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The sources of pharmaceuticals for problematic users of benzodiazepines and prescription opioids.

The Medical journal of Australia·2013
See all related articles

Hepatitis C positive injectors understand risks but may use ineffective strategies to prevent virus transmission. Further research is needed to improve risk management for this population.

Area of Science:

  • Public Health
  • Infectious Disease Epidemiology
  • Behavioral Science

Background:

  • Hepatitis C virus (HCV) prevalence is high (50-60%) among injection drug users.
  • Existing prevention research primarily focuses on initial exposure, neglecting transmission among infected individuals.
  • Effective strategies are needed to reduce onward transmission within the injector community.

Purpose of the Study:

  • To investigate risk management strategies employed by hepatitis C positive injectors.
  • To understand how infected individuals attempt to prevent further HCV transmission.
  • To evaluate the effectiveness of self-reported risk reduction behaviors.

Main Methods:

  • Recruitment of 111 hepatitis C positive injectors.
  • Utilized a questionnaire assessing injecting behaviors and risk reduction options.

Related Experiment Videos

  • Presented injecting vignettes to elicit responses on risk management.

    • Main Results:

    • Most participants recognized risks in various injecting scenarios.
    • Respondents could describe actions to reduce transmission risks.
    • Identified ineffective strategies included unproven needle/syringe decontamination methods and assumptions about other users' knowledge.

    Conclusions:

    • While hepatitis C positive injectors acknowledge transmission risks, their implemented strategies are not always effective.
    • There is a need for education on proven risk reduction methods for preventing further HCV spread.
    • Future interventions should address misconceptions and promote evidence-based practices among injectors.